Koninklijke Philips PHG

NYSE PHG
$24.76 -0.35 (-1.39%)
As of: Sep 29, 2026 · 3:59 PM EDT
Key Stats
Market Cap24.18 Bn
P/E14.30
P/S1.17
Div. Yield3.94
Total Debt (Qtr)8.73 Bn
Revenue Growth (1y) (Qtr)3.21
Add ratio to table…

About

Koninklijke Philips N. V. (Royal Philips) is a global leader in health technology, operating primarily in the Diagnosis & Treatment, Connected Care and Personal Health segments. The company focuses on improving people's health and well-being through meaningful innovation, providing integrated solutions that span from diagnosis and treatment to home-based care and personal wellness. Philips leverages advanced technologies including artificial intelligence, data analytics and…

Read more ↓
Sector: Healthcare Sector rationale The majority of the company's business is focused on health technology for providers and hospitals, specifically through its Diagnosis & Treatment and Connected Care segments which sell MRI, CT, and patient monitoring systems. A secondary sector is required because the Personal Health segment sells everyday essential personal care and oral hygiene products (e.g., Sonicare toothbrushes and grooming tools) that compete with Consumer Staples companies like Colgate-Palmolive and P&G. Industries: +1 more Diagnostic Equipment Diagnostic Equipment Primary Philips' Diagnosis & Treatment segment is a core business driver, providing diagnostic imaging products including Magnetic Resonance Imaging, Ultrasound, Computed Tomography, and Diagnostic X-ray. These products are sold to healthcare providers and hospitals for clinical diagnosis. Medical Devices Medical Devices Secondary The company manufactures therapeutic and surgical medical devices, specifically through its Image Guided Therapy Business which delivers integrated interventional imaging systems and smart devices like the Azurion platform. Home Health and Senior Care Home Health and Senior Care Secondary The Connected Care segment provides sleep and respiratory care solutions, including Philips Respironics devices for sleep apnea and chronic respiratory conditions used in home settings. Classified using BQ-MICS CIK: 0000313216

Geographical areas [axis] Breakdown of Revenue (2025)

Segments [axis] Breakdown of Revenue (2025)

Peer group

Peer Comparison

Companies in the Diagnostic Equipment
View all peers
S.No. Ticker Company Market CapP/EP/STotal Debt (Qtr)
1 TMO Thermo Fisher Scientific Inc. 250.84 Bn36.135.4142.55 Bn
2 ABT Abbott Laboratories 174.73 Bn32.403.7532.61 Bn
3 DHR Danaher Corp /De/ 159.85 Bn40.066.3726.56 Bn
4 ISRG Intuitive Surgical Inc 146.79 Bn46.7913.30-
5 MDT Medtronic plc 114.54 Bn21.893.0528.15 Bn
6 SYK Stryker Corp 105.67 Bn28.334.0914.94 Bn
7 BSX Boston Scientific Corp 63.93 Bn17.653.0412.62 Bn
8 PHG Koninklijke Philips Nv 24.18 Bn14.301.178.73 Bn